NASDAQ: MVIS
Microvision Inc Stock Forecast, Predictions & Price Target

Analyst price target for MVIS

Based on 3 analysts offering 12 month price targets for Microvision Inc

Min Forecast
$2.00+63.93%
Avg Forecast
$2.50+104.92%
Max Forecast
$3.00+145.9%

Should I buy or sell MVIS stock?

Based on 3 analysts offering ratings for Microvision Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MVIS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MVIS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MVIS stock forecasts and price targets.

MVIS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-21
lockedlocked$00.00+00.00%2025-09-02
lockedlocked$00.00+00.00%2025-08-11

1 of 1

Forecast return on equity

Is MVIS forecast to generate an efficient return?

Company
N/A
Industry
24.22%
Market
146.21%

Forecast return on assets

Is MVIS forecast to generate an efficient return on assets?

Company
N/A
Industry
14.21%

MVIS earnings per share forecast

What is MVIS's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.22
Avg 2 year Forecast
-$0.20
Avg 3 year Forecast
-$0.15

MVIS revenue forecast

What is MVIS's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$2.6M-38.81%
Avg 2 year Forecast
$25.4M+485.89%
Avg 3 year Forecast
$48.2M+1,012.64%
MVIS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MVIS revenue growth forecast

How is MVIS forecast to perform vs Scientific & Technical Instruments companies and vs the US market?

Company
123.22%
Industry
5.17%
Market
25.21%
MVIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MVIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MVIS vs Scientific & Technical Instrument Stocks

TickerPricePrice TargetUp/downsideConsensus
MVIS$1.22$2.50+104.92%Strong Buy
MLAB$76.89$67.00-12.86%Hold
WRAP$2.66N/AN/A
VPG$35.96N/AN/A
GNSS$2.17$5.75+164.98%Buy

Microvision Stock Forecast FAQ

Is Microvision Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MVIS) stock is to Strong Buy MVIS stock.

Out of 3 analysts, 3 (100%) are recommending MVIS as a Strong Buy, 0 (0%) are recommending MVIS as a Buy, 0 (0%) are recommending MVIS as a Hold, 0 (0%) are recommending MVIS as a Sell, and 0 (0%) are recommending MVIS as a Strong Sell.

If you're new to stock investing, here's how to buy Microvision stock.

What is MVIS's earnings growth forecast for 2025-2027?

(NASDAQ: MVIS) Microvision's forecast annual earnings growth rate of N/A is not forecast to beat the US Scientific & Technical Instruments industry's average forecast earnings growth rate of 19.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.04%.

Microvision's earnings in 2025 is -$99,381,000.On average, 4 Wall Street analysts forecast MVIS's earnings for 2025 to be -$55,934,292, with the lowest MVIS earnings forecast at -$53,740,791, and the highest MVIS earnings forecast at -$57,579,419. On average, 4 Wall Street analysts forecast MVIS's earnings for 2026 to be -$50,849,357, with the lowest MVIS earnings forecast at -$48,855,264, and the highest MVIS earnings forecast at -$52,344,926.

In 2027, MVIS is forecast to generate -$38,137,018 in earnings, with the lowest earnings forecast at -$39,084,212 and the highest earnings forecast at -$36,641,448.

What is MVIS's revenue growth forecast for 2025-2027?

(NASDAQ: MVIS) Microvision's forecast annual revenue growth rate of 123.22% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 5.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.21%.

Microvision's revenue in 2025 is $4,329,000.On average, 4 Wall Street analysts forecast MVIS's revenue for 2025 to be $660,293,854, with the lowest MVIS revenue forecast at $293,131,586, and the highest MVIS revenue forecast at $1,045,402,953. On average, 4 Wall Street analysts forecast MVIS's revenue for 2026 to be $6,322,020,769, with the lowest MVIS revenue forecast at $5,374,079,083, and the highest MVIS revenue forecast at $7,257,997,900.

In 2027, MVIS is forecast to generate $12,005,931,962 in revenue, with the lowest revenue forecast at $11,344,890,323 and the highest revenue forecast at $12,562,782,271.

What is MVIS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: MVIS) forecast ROA is N/A, which is lower than the forecast US Scientific & Technical Instruments industry average of 14.21%.

What is MVIS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MVIS price target, the average MVIS price target is $2.50, with the highest MVIS stock price forecast at $3.00 and the lowest MVIS stock price forecast at $2.00.

On average, Wall Street analysts predict that Microvision's share price could reach $2.50 by Oct 21, 2026. The average Microvision stock price prediction forecasts a potential upside of 104.92% from the current MVIS share price of $1.22.

What is MVIS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: MVIS) Microvision's current Earnings Per Share (EPS) is -$0.44. On average, analysts forecast that MVIS's EPS will be -$0.22 for 2025, with the lowest EPS forecast at -$0.22, and the highest EPS forecast at -$0.23. On average, analysts forecast that MVIS's EPS will be -$0.20 for 2026, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.21. In 2027, MVIS's EPS is forecast to hit -$0.15 (min: -$0.16, max: -$0.15).

What is MVIS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: MVIS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.